Commandité
EGFR-TKI for Advanced NSCLC Market 2034: Emerging Technologies Reshaping Precision Lung Cancer Care
The Global EGFR-TKI for Advanced NSCLC Market is projected to reach US$ 14.56 billion by 2034, up from US$ 7.93 billion in 2025, registering a CAGR of 7.89% during 2026–2034. The market is expanding as precision oncology becomes increasingly important in the treatment of advanced non-small cell lung cancer (NSCLC), particularly among patients whose tumors harbor...
0 Commentaires 0 Parts 69 Vue 0 Aperçu
Commandité
Commandité